Alkem Laboratories has become the first Indian drugmaker to diversify into medical devices after partnering with US-based Exactech to manufacture and market Exactech's joint replacement implants in India. Exactech will provide Alkem MedTech access to its designs, technology, and marketing rights. The endeavor is expected to commercialize in 1-2 years, targeting India's growing orthopaedic market.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.